Tessier Maude 4
4 · Ikena Oncology, Inc. · Filed Feb 4, 2022
Insider Transaction Report
Form 4
Tessier Maude
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-02+40,000→ 40,000 totalExercise: $11.45Exp: 2032-02-02→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to this option shall vest and become exercisable on January 1, 2023, with the remainder vesting in 36 substantially equal monthly installments thereafter.